Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. (CAPR) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
capr · stock forecast · 10 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 10 Wall Street analysts in the past 3 months
Buy
10 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$62.00
Consensus
$48.75
+87.2% upside
Low
$38.00
Median: $47.5 · Last Close: $26.05
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$48.75
87.2% upside
High Target
$62
138.0%
Low Target
$38
45.9%
Current Price
$26.05
as of today
Based on analyst price targets, the CAPR stock price prediction for the next 12 months ranges from $38 to $62. The consensus CAPR price forecast of $48.75 implies 87.2% upside from the current price of $26.05.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $25.00 | ↓ 4.00% |
1-day model range: $24.81–$25.2. Peak: $25.2 (-4.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CAPR · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-13 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-03-13 | B. Riley Securities | Maintains | Buy→Buy |
| 2026-03-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-15 | B. Riley Securities | Maintains | Buy→Buy |
| 2025-12-10 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-12-08 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-12-04 | Maxim Group | Maintains | Buy→Buy |
| 2025-12-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Capricor Therapeutics, Inc. (CAPR) stock. Of the recent 49 rating actions, 0 were upgrades and 0 were downgrades. 10 analysts currently cover CAPR.
Analyst Recommendation Trends
CAPR analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$117M
↓ 52.2% YoY
Revenue Next Year
$105M
↓ 10.9% YoY
EPS This Year
$-0.59
EPS Next Year
$-0.69
↑ 17.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast CAPR EPS of $-0.59 for the current fiscal year, based on estimates from 7 analysts. The CAPR revenue forecast is $117M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CAPR stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CAPR price target is $48.75 (+87.2% upside), with an analyst consensus of Buy.
The CAPR short-term stock prediction for tomorrow is $25.00 (-4.00%).
Capricor Therapeutics, Inc. trades on NASDAQ under the ticker CAPR. The CAPR stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
CAPR forecast · 8 questionsAccording to 10 Wall Street analysts, the average 12-month CAPR price target is $48.75, with a high forecast of $62.00 and a low of $38.00. The median price target is shown in the chart above when available. This implies +87.2% potential upside from the current price of $26.05.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.